Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMC 306587)

Published in EMBO J on August 01, 2000

Authors

R T Zong1, C Das, P W Tucker

Author Affiliations

1: Department of Molecular Genetics and The Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, USA.

Articles citing this

PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev (2001) 5.79

Histone recognition and large-scale structural analysis of the human bromodomain family. Cell (2012) 5.15

SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev (2003) 2.17

Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia. Epigenetics (2012) 1.29

Sp100 interacts with ETS-1 and stimulates its transcriptional activity. Mol Cell Biol (2002) 1.11

Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression. J Virol (2011) 1.09

Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1. J Virol (2002) 1.03

Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation. J Virol (2009) 0.99

Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer. Mol Cancer (2007) 0.99

SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage. J Biol Chem (2008) 0.99

Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright. EMBO J (2009) 0.96

Bright/Arid3A acts as a barrier to somatic cell reprogramming through direct regulation of Oct4, Sox2, and Nanog. Stem Cell Reports (2014) 0.93

A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes. Mol Cell Biol (2006) 0.93

Sp100A promotes chromatin decondensation at a cytomegalovirus-promoter-regulated transcription site. Mol Biol Cell (2013) 0.86

Subnuclear cyclin D3 compartments and the coordinated regulation of proliferation and immunoglobulin variable gene repression. J Exp Med (2012) 0.80

Nuclear domain 10 of the viral aspect. World J Virol (2013) 0.80

The Bright Side of Hematopoiesis: Regulatory Roles of ARID3a/Bright in Human and Mouse Hematopoiesis. Front Immunol (2014) 0.79

Characterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcription. Mol Immunol (2011) 0.78

SP140L, an Evolutionarily Recent Member of the SP100 Family, Is an Autoantigen in Primary Biliary Cirrhosis. J Immunol Res (2015) 0.77

Host cell restriction factors that limit transcription and replication of human papillomavirus. Virus Res (2016) 0.75

Arid3b Is Critical for B Lymphocyte Development. PLoS One (2016) 0.75

Articles cited by this

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30

SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell (1998) 6.62

A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell (1994) 6.52

Structure and function in the nucleus. Science (1998) 6.26

Macromolecular domains within the cell nucleus. Annu Rev Cell Biol (1993) 5.90

Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature (1998) 5.63

Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell (1994) 5.37

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature (1998) 5.30

Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J (1998) 5.15

Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J Gen Virol (1993) 4.32

The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J Gen Virol (1994) 4.32

The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J (1994) 4.29

The SWI-SNF complex: a chromatin remodeling machine? Trends Biochem Sci (1995) 4.20

The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol (1996) 3.91

Identification of a novel nuclear domain. J Cell Biol (1991) 3.91

A nuclear DNA attachment element mediates elevated and position-independent gene activity. Nature (1989) 3.80

PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene (1996) 3.73

Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev (1996) 3.63

The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins. Nucleic Acids Res (1992) 3.57

Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature (1997) 3.16

G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell (1991) 2.87

Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol (1990) 2.73

PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol (1994) 2.68

A B-cell coactivator of octamer-binding transcription factors. Nature (1995) 2.67

Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A (1998) 2.59

Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J Cell Biol (1997) 2.50

Scaffold-associated regions: cis-acting determinants of chromatin structural loops and functional domains. Curr Opin Genet Dev (1992) 2.42

An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol (1998) 2.20

The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev (1995) 2.19

Chromatin components as part of a putative transcriptional repressing complex. Proc Natl Acad Sci U S A (1998) 2.14

The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc Natl Acad Sci U S A (1998) 2.05

Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.92

Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J Cell Biol (1995) 1.92

Dependence of enhancer-mediated transcription of the immunoglobulin mu gene on nuclear matrix attachment regions. Science (1994) 1.91

Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nat Genet (1997) 1.88

Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J Cell Biochem (1995) 1.86

Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol Cell Biol (1993) 1.83

Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science (1996) 1.72

The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol (1998) 1.69

Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0. J Virol (1994) 1.66

The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J Virol (1996) 1.61

The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature (1997) 1.61

PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res (1995) 1.54

Nuclear dots: actors on many stages. Immunobiology (1997) 1.45

The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood (1995) 1.44

Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body-associated PML protein. Exp Cell Res (1995) 1.40

The PML nuclear compartment and cancer. Biochim Biophys Acta (1996) 1.27

Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. EMBO J (1996) 1.27

LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies. Blood (1996) 1.26

Identification and characterization of a leukocyte-specific component of the nuclear body. J Biol Chem (1996) 1.24

Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator. Mol Cell Biol (1999) 1.21

Make it or break it: the role of ubiquitin-dependent proteolysis in cellular regulation. Trends Cell Biol (1995) 1.17

Novel protein-DNA interactions associated with increased immunoglobulin transcription in response to antigen plus interleukin-5. Mol Cell Biol (1991) 1.09

A model for chromatin opening: stimulation of topoisomerase II and restriction enzyme cleavage of chromatin by distamycin. EMBO J (1993) 1.07

Expression of bright at two distinct stages of B lymphocyte development. J Immunol (1998) 1.02

Structural and functional heterogeneity of nuclear bodies. Mol Cell Biol (1999) 1.02

Attachment to the nuclear matrix mediates specific alterations in chromatin structure. Proc Natl Acad Sci U S A (1998) 1.00

Expression of the (recombinant) endogenous immunoglobulin heavy-chain locus requires the intronic matrix attachment regions. Mol Cell Biol (1997) 0.99

The establishment of active chromatin domains. Cold Spring Harb Symp Quant Biol (1998) 0.99

Mutually exclusive interaction of a novel matrix attachment region binding protein and the NF-muNR enhancer repressor. Implications for regulation of immunoglobulin heavy chain expression. J Biol Chem (1995) 0.91

Interrelationships of nuclear structure and transcriptional control: functional consequences of being in the right place at the right time. J Cell Biochem (1998) 0.89

A model for chromatin remodeling by the SWI/SNF family. Cold Spring Harb Symp Quant Biol (1998) 0.88

Differential regulation of immunoglobulin gene transcription via nuclear matrix-associated regions. Cold Spring Harb Symp Quant Biol (1999) 0.88

Banded krait minor-satellite (Bkm)-associated Y chromosome-specific repetitive DNA in mouse. Nucleic Acids Res (1994) 0.84

Articles by these authors

Cloning human fetal gamma globin and mouse alpha-type globin DNA: preparation and screening of shotgun collections. Science (1978) 8.24

Interaction of cell-type-specific nuclear proteins with immunoglobulin VH promoter region sequences. Nature (1986) 4.21

Limited diversity of gamma delta antigen receptor genes of Thy-1+ dendritic epidermal cells. Cell (1988) 3.88

Mapping of heavy chain genes for mouse immunoglobulins M and D. Science (1980) 3.61

Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. Science (1979) 3.21

A mouse alpha-globin-related pseudogene lacking intervening sequences. Nature (1980) 2.92

The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood (2001) 2.77

Cloning human fetal gamma globin and mouse alpha-type globin DNA: characterization and partial sequencing. Science (1978) 2.25

The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev (1995) 2.19

Structure of genes for membrane and secreted murine IgD heavy chains. Nature (1982) 2.15

Mouse immunoglobulin D: messenger RNA and genomic DNA sequences. Science (1980) 2.11

Unusual sequences in the murine immunoglobulin mu-delta heavy-chain region. Nature (1984) 2.08

Relative position and strengths of poly(A) sites as well as transcription termination are critical to membrane versus secreted mu-chain expression during B-cell development. Genes Dev (1987) 2.07

Regulation of T-cell receptor gamma-chain RNA expression in murine Thy-1+ dendritic epidermal cells. Nature (1987) 2.00

Increasing prevalence of asthma diagnosis and symptoms in children is confined to mild symptoms. Thorax (2001) 1.95

[Unexplained deaths in minors in the Amsterdam-Zaandam region in 1990-2004 and the estimated number that will be considered for further investigation into the cause of death (the NODO procedure)]. Ned Tijdschr Geneeskd (2007) 1.92

The molecular biology of immunoglobulin D. Nature (1984) 1.89

Transcriptional regulation of the mu-delta heavy chain locus in normal murine B lymphocytes. J Exp Med (1984) 1.88

PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors. Mol Cell Biol (2001) 1.85

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart (2005) 1.73

Structure of the constant and 3' untranslated regions of the murine gamma 2b heavy chain messenger RNA. Science (1979) 1.68

ARID proteins come in from the desert. Trends Biochem Sci (2000) 1.67

J genes for heavy chain immunoglobulins of mouse. Science (1980) 1.65

Carers' perception of childhood asthma and its management in a selected Pakistani community. Arch Dis Child (2002) 1.60

NonO, a non-POU-domain-containing, octamer-binding protein, is the mammalian homolog of Drosophila nonAdiss. Mol Cell Biol (1993) 1.57

A new human immunoglobulin VH family preferentially rearranged in immature B-cell tumours. Nature (1988) 1.55

Mouse IgA heavy chain gene sequence: implications for evolution of immunoglobulin hinge axons. Proc Natl Acad Sci U S A (1981) 1.54

Mouse immunoglobulin D: construction and characterization of a cloned delta chain cDNA. Proc Natl Acad Sci U S A (1980) 1.50

Staphylococcal nuclease reviewed: a prototypic study in contemporary enzymology. I. Isolation; physical and enzymatic properties. Mol Cell Biochem (1978) 1.50

Poly(A) site choice rather than splice site choice governs the regulated production of IgM heavy-chain RNAs. Proc Natl Acad Sci U S A (1988) 1.46

Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice. Blood (2001) 1.45

Delta is the Cx-gene product in the gamma/delta antigen receptor of dendritic epidermal cells. Nature (1988) 1.41

The murine immunoglobulin alpha gene expresses multiple transcripts from a unique membrane exon. EMBO J (1983) 1.34

Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid. Proc Natl Acad Sci U S A (1976) 1.33

Production and characterization of recombinant human Ku antigen. Nucleic Acids Res (1994) 1.32

Structural analysis of the murine IgG3 constant region gene. EMBO J (1984) 1.30

Simultaneous expression of immunoglobulin mu and delta heavy chains by a cloned B-cell lymphoma: a single copy of the VH gene is shared by two adjacent CH genes. Proc Natl Acad Sci U S A (1982) 1.29

Protein-nucleotide contacts in the immunoglobulin heavy-chain promoter region. Proc Natl Acad Sci U S A (1987) 1.29

Murine natural killer cells do not express functional transcripts of the alpha-, beta-, or gamma-chain genes of the T cell receptor. J Immunol (1986) 1.28

Alternative expression of secreted and membrane forms of immunoglobulin mu-chain is regulated by transcriptional termination in stable plasmacytoma transfectants. J Immunol (1988) 1.27

Staphylococcal nuclease reviewed: a prototypic study in contemporary enzymology. II. Solution studies of the nucleotide binding site and the effects of nucleotide binding. Mol Cell Biochem (1979) 1.26

Structure of hemoglobins Zürich [His E7(63)beta replaced by Arg] and Sydney [Val E11(67)beta replaced by Ala] and role of the distal residues in ligand binding. Proc Natl Acad Sci U S A (1978) 1.25

Organization of the murine immunoglobulin VH complex in the inbred strains. EMBO J (1987) 1.22

Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator. Mol Cell Biol (1999) 1.21

T cell receptor genes do not rearrange or express functional transcripts in natural killer cells of scid mice. J Immunol (1987) 1.21

Murine natural killer cells express functional Fc gamma receptor II encoded by the Fc gamma R alpha gene. J Exp Med (1989) 1.20

Staphylococcal nuclease reviewed: a prototypic study in contemporary enzymology. IV. The nuclease as a model for protein folding. Mol Cell Biochem (1979) 1.20

Regulation of the expression of multiple class II genes in murine B cells by B cell stimulatory factor-1 (BSF-1). J Immunol (1986) 1.17

Double isotype production by a neoplastic B cell line. II. Allelically excluded production of mu and gamma 1 heavy chains without CH gene rearrangement. J Exp Med (1986) 1.17

Construction of recombinant DNA by exonuclease recession. Nucleic Acids Res (1993) 1.16

The ubiquitous octamer-binding protein(s) is sufficient for transcription of immunoglobulin genes. Mol Cell Biol (1990) 1.13

De novo protein design: crystallographic characterization of a synthetic peptide containing independent helical and hairpin domains. Proc Natl Acad Sci U S A (2000) 1.12

Molecular cloning of equine herpesvirus type 1 DNA: analysis of standard and defective viral genomes and viral sequences in oncogenically transformed cells. Proc Natl Acad Sci U S A (1981) 1.12

Human immunoglobulin D: genomic sequence of the delta heavy chain. Science (1985) 1.12

DNA-binding properties and secondary structural model of the hepatocyte nuclear factor 3/fork head domain. Proc Natl Acad Sci U S A (1993) 1.11

Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. Science (1982) 1.11

Germ-line sequence of the DH segment employed in Ars-A antibodies: implications for the generation of junctional diversity. J Immunol (1986) 1.11

The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells. Leukemia (2006) 1.11

Identification of a matrix-associated region 5' of an immunoglobulin heavy chain variable region gene. Mol Cell Biol (1991) 1.11

NonO enhances the association of many DNA-binding proteins to their targets. Nucleic Acids Res (1997) 1.11

Phylogenetic conservation of immunoglobulin heavy chains: direct comparison of hamster and mouse Cmu genes. Nucleic Acids Res (1985) 1.10

Novel protein-DNA interactions associated with increased immunoglobulin transcription in response to antigen plus interleukin-5. Mol Cell Biol (1991) 1.09

Diagnostic and treatment behaviour in children with chronic respiratory symptoms: relationship with socioeconomic factors. Thorax (2002) 1.09

Induction of immunoglobulin mu mRNA in a B cell transfectant stimulated with interleukin-5 and a T-dependent antigen. J Immunol (1989) 1.07

Immunoglobulin heavy chain enhancer is located near or in an initiation zone of chromosomal DNA replication. Proc Natl Acad Sci U S A (1993) 1.06

Staphylococcal nuclease reviewed: a prototypic study in contemporary enzymology. III. Correlation of the three-dimensional structure with the mechanisms of enzymatic action. Mol Cell Biochem (1979) 1.06

Mouse spleen and IgD-secreting plasmacytomas contain multiple IgD delta chain RNAs. Nature (1982) 1.05

Molecular analysis of the t(2;14) translocation of childhood chronic lymphocytic leukemia. Science (1986) 1.05

Immunoglobulin D switching can occur through homologous recombination in human B cells. Mol Cell Biol (1990) 1.05

Regulation of IgM and IgD synthesis in B lymphocytes. I. Changes in biosynthesis of mRNA for mu- and delta-chains. J Immunol (1984) 1.04

Unilateral pulmonary agenesis: an uncommon cause of lower zone lung opacity. Indian J Chest Dis Allied Sci (2005) 1.02

Natural killer cells in the thymus. Studies in mice with severe combined immune deficiency. J Immunol (1990) 1.02

A conserved heptamer upstream of the IgH promoter region octamer can be the site of a coordinate protein-DNA interaction. Nucleic Acids Res (1988) 1.00

Illegitimate recombination generates a class switch from C mu to C delta in an IgD-secreting plasmacytoma. Proc Natl Acad Sci U S A (1984) 0.97

Effect of lipopolysaccharide stimulation on the transcription and translation of messenger RNA for cell surface immunoglobulin M. J Exp Med (1982) 0.97

The human immunoglobulin C mu-C delta locus: complete nucleotide sequence and structural analysis. Int Immunol (1989) 0.97

Transcriptional activation by a matrix associating region-binding protein. contextual requirements for the function of bright. J Biol Chem (2001) 0.96

The responsiveness and validity of the CAMPHOR Utility Index. Eur Respir J (2008) 0.96

Double isotype production by a neoplastic B cell line. I. Cellular and biochemical characterization of a variant of BCL1 that expresses and secretes both IgM and IgG1. J Exp Med (1986) 0.95

Thy-1+ epidermal cells in nude mice are distinct from their counterparts in thymus-bearing mice. A study of morphology, function, and T cell receptor expression. J Immunol (1988) 0.95

Nuclear NonO/p54(nrb) protein is a nonclassical carbonic anhydrase. J Biol Chem (2000) 0.95

Extensive and selective mutation of a rearranged VH5 gene in human B cell chronic lymphocytic leukemia. J Exp Med (1992) 0.95

Molecular characterization of the A/J J558 family of heavy chain variable region gene segments. J Mol Biol (1988) 0.95

The effects of cytokines and adherent cells on the interleukin 4-mediated induction of Ia antigens on resting B cells. Cell Immunol (1987) 0.95

Expression and sequence analyses of serum amyloid A in the Syrian hamster. Biochemistry (1989) 0.94

Differential expression of the class I MHC genes in the embryo and placenta during midgestational development in the mouse. J Immunol (1989) 0.94

NMR structure of the mature dimer initiation complex of HIV-1 genomic RNA. FEBS Lett (1999) 0.92

Fibroma of the tonsil. J Laryngol Otol (1969) 0.92

Protection analysis (or "footprinting") of specific protein-DNA complexes in crude nuclear extracts using methidiumpropyl-EDTA-iron (II). Biotechniques (1989) 0.92

T cell receptor gamma and delta gene junctional sequences in SCID mice: excessive P nucleotide insertion. J Exp Med (1991) 0.92

Determination of vector: insert junctions in lambda gt10 cDNAs that do not recut with EcoRI. Nucleotide sequence of the lambda imm434 HindIII-EcoRI DNA fragment encoding part of the cI protein. Nucleic Acids Res (1987) 0.92

Analysis and comparison of the mouse and human immunoglobulin heavy chain JH-Cmu-Cdelta locus. Mol Phylogenet Evol (1996) 0.90

Lack of somatic hypermutation of IG V(H) genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene. Leukemia (2002) 0.90

Differential structure-function requirements of the transmembranal domain of the B cell antigen receptor. J Exp Med (1992) 0.89

The effect of T cell-derived lymphokines on the levels of isotype-specific RNA in normal B cells. J Mol Cell Immunol (1985) 0.89

Role of argon laser trabeculoplasty as primary and secondary therapy in open angle glaucoma in Indian patients. Br J Ophthalmol (2002) 0.89